Schlumberger offers a compelling value play with strong fundamentals, robust profitability, and growth driven by cutting-edge technology and AI, trading near 52-week lows. Alexandria Real Estate is a high-quality REIT with mission-critical life science properties, benefiting from sticky tenant relationships and a solid growth pipeline, also trading near 52-week lows. Both SLB and ARE present at...
The recent market selloff, driven by the Fed's revised rate-cut forecast, has made high-quality REITs attractively priced for long-term dividend growth investors. Despite poor stock price performance, REITs have strong fundamentals, with favorable earnings yield spreads and dividend yields compared to the broader market. REITs are undervalued due to being treated as bond proxies, but their stro...
Going into 2024, the consensus was that REITs would surge higher. While the base rates have dropped, the REIT investment case has failed. Yet, as long as the objective is to extract durable income, I would argue that now is the right time to make huge moves in the REIT segment.
The real estate cycle will finally transition from the "Recession" phase to the "Recovery" phase in 2025. Muted supply growth will be the silver-lining to the brutal three-year bear market. False Start: REITs surged 20% leading up to the Fed's initial "jumbo" interest rate cut in September, but have hit the skids once again since the rate cuts actually began. Historically Cheap: REITs have unde...
Dividend growth stocks, though not often the most exciting, can offer the potential for growing wealth and passive income over the long run. Every month, we screen for potential opportunities, starting with initial parameters, including dividend safety, growth, and consistency. Of course, further due diligence is essential; these initial screenings are just that “initial” and highlight potentia...
Alexandria Real Estate offers a 5.2% yield, strong financial health, and a unique life sciences-focused REIT model with robust occupancy and growth prospects. Plains All American provides a 7.2% yield, benefits from growing Permian Basin volumes, and has a disciplined capital allocation with a strong balance sheet. Both ARE and PAA are undervalued, presenting high-yield opportunities for income...
ARE is a leading REIT in life science properties, facing challenges due to a downturn in the life science market. ARE's shares have dropped 55% from their peak but continue to grow FFO per share. ARE's strategic moves include a $500 million share repurchase plan.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.